News about Global Pharma

UP Govt Announces to Produce and Export in Pharma Sector Soon

Chief Minister Yogi Adityanath has announced that Uttar Pradesh will become a producer and exporter of pharmaceutical products soon.

Global Pharma | 19/03/2024 | By Manvi |  827

Eris Lifesciences Announces Acquisition of Biocon Biologics

Eris Lifesciences Ltd. has recently acquired Biocon Biologics’ Branded Formulations business in India in a deal worth INR 1,242 crore.

Global Pharma | 19/03/2024 | By Manvi |  602

Sanofi India Forges Exclusive Distribution Partnership with Emcure Pharma

Sanofi India has signed an exclusive distribution and promotion agreement with Emcure Pharma for Sanofi’s cardiovascular products in India.

Global Pharma | 19/03/2024 | By Manvi |  1197

Sulzer to Deliver Technology and Key Equipment to India?s First Bioplastics Plant

Sulzer to deliver technology and key equipment to India’s first bioplastics plant to boost sustainable manufacturing in the region

Global Pharma | 18/03/2024 | By Manvi |  486

Neupulse Secures Funding to Advance World's First Wearable Device to Tackle Tourettes Syndrome

Neupulse has secured funding to advance the world’s first wearable device aimed at tackling Tourettes Syndrome (TS) and other tic disorders towards commercialization.

Global Pharma | 18/03/2024 | By Manvi |  638

Noramco Launches Noramco Group to Strengthen North American Pharmaceutical Supply Chain

This initiative integrates subsidiaries Purisys, Noramco, and recently acquired drug product CDMO, Halo Pharma, to enhance the region's clinical and commercial API and drug product supply chain.

Global Pharma | 18/03/2024 | By Abha |  542

Aptar Expands North American Capacity to Meet Growing Demand for Drug Delivery Systems

This investment aims to address the increasing demand for proprietary drug delivery systems in both prescription and consumer healthcare markets across North America, benefiting local customers.

Global Pharma | 18/03/2024 | By Abha |  506

BeiGene Receives FDA Approval for TEVIMBRA

BeiGene announced that the U.S. Food and Drug Administration (FDA) has approved TEVIMBRA ® (tislelizumab) as a treatment for adult patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) who have previously received unresectable or metastatic esophageal squamous cell carcinoma (ESCC).

Global Pharma | 16/03/2024 | By Manvi |  712

Optinose Receives FDA Approval for XHANCE Nasal Spray to Treat Chronic Sinusitis Without Nasal Polyps

Chronic sinusitis, affecting around 30 million adults in the United States, is a prevalent chronic condition that significantly impacts patients' quality of life.

Global Pharma | 16/03/2024 | By Manvi |  1645

Bioretec Receives FDA Breakthrough Device Designation for RemeOs Spinal Interbody Cage Implant

The RemeOs Spinal Interbody Cages, designed to restore intervertebral height and facilitate intervertebral body fusion in the cervical spine, are poised to revolutionize treatment options for patients with spinal conditions.

Global Pharma | 16/03/2024 | By Manvi |  654